Occupational Asthma From Epoxy Compounds. 2019

Hille Suojalehto, and Joaquin Sastre, and Emilia Merimaa, and Irmeli Lindström, and Katri Suuronen
Finnish Institute of Occupational Health, Helsinki, Finland. Electronic address: hille.suojalehto@ttl.fi.

Two-component epoxy resin systems (ERSs) composed of epoxy resin and polyamine hardeners are extensively used in industrial and construction coating. Triglycidyl isocyanurate (TGIC) is another type of epoxy derivative, mostly encountered in polyester powder paints. Epoxy compounds are well-known skin sensitizers, but their respiratory-sensitizing potential is largely unknown. To report patients examined for occupational asthma (OA) from epoxy compounds. We retrospectively reviewed patient files of cases tested with a placebo-controlled specific inhalation challenge (SIC) according to their workplace exposure-either by mixing epoxy resin and the polyamine hardener of a 2-component paint or by dusting or heating TGIC-containing powder paint. The data were collected from the Finnish Institute of Occupational Health, Helsinki, Finland, and at Fundación Jiménez Díaz Hospital, Madrid, Spain, during 1997 to 2018. We also measured airborne polyamine and solvent vapors at the workplace and during SIC with ERSs. Altogether 113 patients with work-related asthma symptoms underwent SIC with ERSs. Fifteen cases (13%) had positive SIC reactions confirming OA; in 12 cases reactions were late-type, in 1 case early, and in 2 cases combined. The median duration of exposure for patients with OA was 10 years; 2 of them (13%) had a diagnosis of allergic contact dermatitis from ERS compounds. In addition, 3 cases had a positive SIC reaction to TGIC. The airborne polyamine levels measured were low. ERSs and TGIC can cause sensitizer-induced OA in some exposed workers. Respiratory exposure to ERSs is difficult to demonstrate using air measurements.

UI MeSH Term Description Entries
D007114 Immunization Deliberate stimulation of the host's immune response. ACTIVE IMMUNIZATION involves administration of ANTIGENS or IMMUNOLOGIC ADJUVANTS. PASSIVE IMMUNIZATION involves administration of IMMUNE SERA or LYMPHOCYTES or their extracts (e.g., transfer factor, immune RNA) or transplantation of immunocompetent cell producing tissue (thymus or bone marrow). Immunologic Stimulation,Immunostimulation,Sensitization, Immunologic,Variolation,Immunologic Sensitization,Immunological Stimulation,Sensitization, Immunological,Stimulation, Immunologic,Immunizations,Immunological Sensitization,Immunological Sensitizations,Immunological Stimulations,Sensitizations, Immunological,Stimulation, Immunological,Stimulations, Immunological,Variolations
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011073 Polyamines Amine compounds that consist of carbon chains or rings containing two or more primary amino groups. Polyamine
D012130 Respiratory Hypersensitivity A form of hypersensitivity affecting the respiratory tract. It includes ASTHMA and RHINITIS, ALLERGIC, SEASONAL. Airway Hyperresponsiveness,Hypersensitivity, Respiratory,Airway Hyper-Responsiveness,Airway Hyper Responsiveness,Airway Hyperresponsivenesses,Hyper-Responsiveness, Airway,Hyperresponsiveness, Airway,Respiratory Hypersensitivities
D004852 Epoxy Compounds Organic compounds that include a cyclic ether with three ring atoms in their structure. They are commonly used as precursors for POLYMERS such as EPOXY RESINS. Epoxide,Epoxides,Epoxy Compound,Oxiranes,Compound, Epoxy,Compounds, Epoxy
D005260 Female Females
D005387 Finland A country in northern Europe, bordering the Baltic Sea, Gulf of Bothnia, and Gulf of Finland, between Sweden and Russia. The capital is Helsinki. Aland Islands,Åland Islands
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000280 Administration, Inhalation The administration of drugs by the respiratory route. It includes insufflation into the respiratory tract. Drug Administration, Inhalation,Drug Administration, Respiratory,Drug Aerosol Therapy,Inhalation Drug Administration,Inhalation of Drugs,Respiratory Drug Administration,Aerosol Drug Therapy,Aerosol Therapy, Drug,Drug Therapy, Aerosol,Inhalation Administration,Administration, Inhalation Drug,Administration, Respiratory Drug,Therapy, Aerosol Drug,Therapy, Drug Aerosol

Related Publications

Hille Suojalehto, and Joaquin Sastre, and Emilia Merimaa, and Irmeli Lindström, and Katri Suuronen
December 2019, Occupational medicine (Oxford, England),
Hille Suojalehto, and Joaquin Sastre, and Emilia Merimaa, and Irmeli Lindström, and Katri Suuronen
September 1990, Contact dermatitis,
Hille Suojalehto, and Joaquin Sastre, and Emilia Merimaa, and Irmeli Lindström, and Katri Suuronen
January 2009, International archives of allergy and immunology,
Hille Suojalehto, and Joaquin Sastre, and Emilia Merimaa, and Irmeli Lindström, and Katri Suuronen
January 1991, Acta dermato-venereologica. Supplementum,
Hille Suojalehto, and Joaquin Sastre, and Emilia Merimaa, and Irmeli Lindström, and Katri Suuronen
December 2017, Occupational medicine (Oxford, England),
Hille Suojalehto, and Joaquin Sastre, and Emilia Merimaa, and Irmeli Lindström, and Katri Suuronen
June 1996, Contact dermatitis,
Hille Suojalehto, and Joaquin Sastre, and Emilia Merimaa, and Irmeli Lindström, and Katri Suuronen
March 1986, Contact dermatitis,
Hille Suojalehto, and Joaquin Sastre, and Emilia Merimaa, and Irmeli Lindström, and Katri Suuronen
August 2000, International archives of occupational and environmental health,
Hille Suojalehto, and Joaquin Sastre, and Emilia Merimaa, and Irmeli Lindström, and Katri Suuronen
June 2017, Occupational medicine (Oxford, England),
Hille Suojalehto, and Joaquin Sastre, and Emilia Merimaa, and Irmeli Lindström, and Katri Suuronen
May 1993, Contact dermatitis,
Copied contents to your clipboard!